A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization
Author:
Funder
Eisai
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology
Reference50 articles.
1. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy;Angeles;Epilepsia,1981
2. The descriptive epidemiology of epilepsy—a review;Banerjee;Epilepsy Res.,2009
3. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double‐blind, placebo‐controlled trial;Biton;Epilepsia,2014
4. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: results of an indirect comparison meta-analysis of RCTs;Brigo;Seizure,2016
5. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials;Bucher;J. Clin. Epidemiol.,1997
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Brivaracetam add-on treatment in pediatric patients with severe drug-resistant epilepsy: Italian real-world evidence;Seizure;2022-11
2. Safety evaluation of perampanel as monotherapy or first adjunctive therapy in patients with epilepsy;Expert Opinion on Drug Safety;2022-10-03
3. The real-world effectiveness and safety of perampanel in Europe: A scoping review;Epilepsy & Behavior;2022-09
4. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials;Epilepsia;2022-06-10
5. Efficacy, tolerability and safety of perampanel in population with pharmacoresistant focal seizures: A systematic review and meta-analysis;Epilepsy Research;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3